臨床泌尿器科77巻13号

2023年12月発行

綜説

前立腺癌に対する小線源治療の現状と展望

著者： 深貝隆志¹

所属機関： ¹昭和大学医学部泌尿器科学講座

ページ範囲：P.1037 - P.1046

要旨

　前立腺癌に対する組織内照射（以下，小線源治療）はその高い治療効果が証明され，限局性前立腺癌の標準治療の1つとして各国の診療ガイドラインにも記載されている．しかし世界的にも，国内でも症例数は減少しつつあることが報告されている．小線源治療もしくは小線源治療＋外照射治療に関する治療成績と他の根治治療である手術，外照射の治療成績を比較した報告は数多くみられており，その成績は他の治療方法よりも劣るものではない．特に高リスクがんに対して小線源治療＋外照射治療＋ホルモン療法は，他の治療法よりも有効である可能性を示す報告もみられている．ここでは前立腺癌に対する小線源治療の現状と治療成績について紹介してみたい．

参考文献

1） Pasteau O, et al : The Radium Treatment of Cancer of the Prostate. Journal d'Urologie （Paris） 4 : 341-366, 1913

2） Holm HH, et al : Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130 : 283-286, 1983

3） Malouff T, et al : Trends in the Use of Radiation Therapy for Stage IIA Prostate Cancer from 2004 to 2013 : A Retrospective Analysis Using the National Cancer Database. Prostate Cancer Prostatic Di 20 : 334-338, 2017

4） Mukherjee K, et al : Trends and Variations in Utilization and Costs of Radiotherapy for Prostate Cancer : A SEER Medicare Analysis from 2007 Through 2016. Brachytherapy 21 : 12-21, 2022

5） Martine JM, et al : The Rise and Fall of Prostate Brachytherapy : Use of Brachytherapy for the Treatment of Localized Prostate Cancer in the National Cancer Data Base. Cancer 120 : 2114-2121, 2014

6） Jemal A, et al : Cancer Statistics, 2007. CA Cancer J Clin 57 : 43-66, 2007

7） Siegel RL, et al : Cancer Statistics, 2015. CA Cancer J Clin 65 : 5-29, 2015

8） 斉藤史郎 : Brachytherapy made in Japan. 第17回前立腺癌密封小線源永久挿入治療研究会記録集. pp43-65, 2022

9） 厚生労働省 : NDBオープンデータ　https://www.mhlw.go.jp/content/12400000/000986944.xlsx （2023年7月30日閲覧）

10） 厚生労働省 : NDBオープンデータ　https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000177182.html （2023年7月30日閲覧）

11） Onozawa M, et al : Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan. Jpn J Clin Oncol 44 : 969-981, 2014

12） NCCN : 前立腺癌ガイドライン2023 ver.2　https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf （2023年7月30日閲覧）

13） EAU : 前立腺癌ガイドライン2023　https://uroweb.org/guidelines/prostate-cancer （2023年7月30日閲覧）

14） 日本泌尿器科学会 （編） : 前立腺癌診療ガイドライン2023年版. メディカルレビュー社, 東京, 2023

15） Cosset JM, et al : Long-Term Results of Permanent Implant Prostate Cancer Brachytherapy : A Single Institution Study of 675 Patients Treated Between 1999 and 2003. Cancer Radiother 20 : 261-267, 2016

16） Wilson C, et al : Ten-Year Outcomes Using Low Dose Rate Brachytherapy for Localized Prostate Cancer : An Update to the first Australian Experience. J Med Imaging Radiat Oncol 60 : 531-538, 2016

17） Langley SEM, et al : Long-Term Oncological Outcomes and Toxicity in 597 Men Aged ≦ 60 Years at Time of Low-Dose-Rate Brachytherapy for Localized Prostate Cancer. BJU Int 121 : 38-45, 2018

18） Jacobsen MG, et al : Results of 14 Years of Brachytherapy for Localized Prostate Cancer in Denmark : The Herlev Cohort. Scand J Urol 52 : 164-168, 2018

19） Lamb DS, et al : A Prospective Audit of the 10-Year Outcomes from Low Dose-Rate Brachytherapy for Early Stage Prostate Cancer. N Z Med J 131 : 13-18, 2018

20） Wiegel T, et al : Results of a Randomized Trial of Treatment Modalities in Patients with Low or Early-Intermediate Risk Prostate Cancer （PREFERE Trial）. J Cancer Res Clin Oncol 147 : 235-242, 2021

21） Moll M, et al : Treatment of Low-Risk Prostate Cancer : A Retrospective Study with 477 Patients Comparing External Beam Radiotherapy and I-125 Seeds Brachytherapy in Terms of Biochemical Control and Late Side Effects. Strahlenther Onkol 197 : 118-123, 2021

22） Urabe F, et al : Long-Term Outcomes of Radical Prostatectomy versus Low-Dose-Rate Brachytherapy in Patients with Intermediate-Risk Prostate Cancer : Propensity Score Matched Comparison. Prostate 83 : 135-141, 2023

23） Morris WJ, et al : Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy （the ASCENDE-RT Trial） : An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. Int J Radiat Oncol Biol Phys 98 : 275-285, 2017

24） Rodda S, et al : ASCENDE-RT : An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing Low Dose- Rate Brachytherapy Boost with Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 98 : 286-295, 2017

25） Ciezki JP, et al : A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 97 : 962-975, 2017

26） Johnson SB, et al : Brachytherapy Boost Utilization and Survival in Unfavorable-Risk Prostate Cancer. Eur Urol 72 : 738-744, 2017

27） Ennis RD, et al : Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer. J Clin Oncol 36 : 1192-1198, 2018

28） Kishan AU, et al : Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA 319 : 896-905, 2018

29） Luo Y, et al : Long-Term Oncologic Outcomes of Radiotherapy Combined with Maximal Androgen Blockade for Localized, High-Risk Prostate Cancer. World J Surg Oncol 16 : 10, 2018

30） Sandler KA, et al : Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma : Results from a Multi-Institutional Consortium Study. Int J Radiat Oncol Biol Phys 101 : 883-888, 2018

31） Kishan AU, et al : Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. JAMA Network Open 4 : e2115312, 2021

32） Aas K, et al : Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens. Eur Urol Open Sci 26 : 55-63, 2021

33） Andruska N, et al : Assessing the Impact of Brachytherapy Boost and Androgen Deprivation Therapy on Survival Outcomes for Patients with Unfavorable Intermediate-Risk Prostate Cancer Patients Treated with External Beam Radiotherapy. Brachytherapy 21 : 617-625, 2022

34） Patel SA, et al : External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer : A Large Multicenter International Consortium Analysis. Int J Radiat Oncol Biol Phys 115 : 645-653, 2023

35） Stock RG, et al : Biologically Effective Dose Values for Prostate Brachytherapy : Effects on PSA Failure and Posttreatment Biopsy Results. Int J Radiat Oncol Biol Phys 64 : 527-533, 2006

36） Carpenter TJ, et al : Outcomes for Patients with Extraprostatic Prostate Cancer Treated with Trimodality Therapy, Including Brachytherapy, External Beam Radiotherapy, and Hormone Therapy. Brachytherapy 10 : 261-268, 2011

37） Bolla M, et al : Long-Term Results with Immediate Androgen Suppression and External Irradiation in Patients with Locally Advanced Prostate Cancer （an EORTC Study） : A Phase III Randomized Trial. Lancet 360 : 103-106, 2002

38） Zietman AL, et al : The Effect of Androgen Deprivation and Radiation Therapy on an Androgen-Sensitive Murine Tumor : An in vitro and in vivo Study. Cancer J Sci Am 3 : 31-36, 1997

39） Pollack A, et al : Quiescence in R3327-G Rat Prostate Tumors After Androgen Ablation. Cancer Res 57 : 2493-2500, 1997

40） Merrick GS, et al : Androgen Deprivation Therapy Does Not Impact Cause-Specific or Overall Survival in High-Risk Prostate Cancer Managed with Brachytherapy and Supplemental External Beam. Int J Radiat Oncol Biol Phys 68 : 34-40, 2007

41） Stock RG, et al : The Relative Importance of Hormonal Therapy and Biological Effective Dose in Optimizing Prostate Brachytherapy Treatment Outcomes. BJU Int 112 : E44-50, 2013

42） Mohiuddin JJ, et al : Variations in Patterns of Concurrent Androgen Deprivation Therapy Use Based on Dose Escalation with External Beam Radiotherapy vs. Brachytherapy Boost for Prostate Cancer. Brachytherapy 18 : 322-331, 2019

43） Kishan AU, et al : Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy with or without a Brachytherapy Boost for Optimal Treatment of High-Risk Prostate Cancer : A Patient-Level Data Analysis of 3 Cohorts. JAMA Oncol 8 : e216871, 2022

44） Yorozu A, et al : Results of a Multicenter, Randomized, Phase 3 Trial of Trimodality Therapy with I-125 Brachytherapy, External Beam Radiation Therapy, and Long- versus Short-Term Androgen Deprivation Therapy for Localized High-Risk Prostate Cancer （TRIP/TRIGU0907）. J Clin Oncol 41 : Issue 6_suppl. Abstract 305　https://meetings.asco.org/abstracts-presentations/search?q=Atsunori%20Yorozu （2023年7月30日閲覧）